Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
Treament | Trials | |||||
---|---|---|---|---|---|---|
Demonstrated or suggested benefit | Inconclusive results | Uncertain results | Safety results | |||
CoronaVac (SinoVac) | 0 | - | - | - | - | |
Covaxin, Bharat Biotech (BBV152) | 0 | - | - | - | - | |
Shifa-Pharmed inactivated vaccine | 0 | - | - | - | - | |
Sinopharm Beijing (BBIBP-CorV) | 0 | - | - | - | - | |
Sinopharm Wuhan | 0 | - | - | - | - |